{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T11:55:35Z","timestamp":1795175735055,"version":"4.10.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Project of Guizhou Provincial Health and Wellness Commission","award":["gzwkj2024-099 and gzwkj2025-608)"],"award-info":[{"award-number":["gzwkj2024-099 and gzwkj2025-608)"]}]},{"name":"Qian Dong Nan Science and Technology Program","award":["qdnkhJz [2023] 14"],"award-info":[{"award-number":["qdnkhJz [2023] 14"]}]},{"DOI":"10.13039\/501100012168","name":"Spark Program","doi-asserted-by":"crossref","award":["XHJH-0048"],"award-info":[{"award-number":["XHJH-0048"]}],"id":[{"id":"10.13039\/501100012168","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14896-1","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T09:26:40Z","timestamp":1756805200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effectiveness and safety of pirfenidone for radiation-induced lung injury in non-small cell lung cancer: a retrospective pilot study"],"prefix":"10.1186","volume":"25","author":[{"given":"Xian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianchu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benlan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengfa","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"14896_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104461","volume":"202","author":"S Chang","year":"2024","unstructured":"Chang S, Lv J, Wang X, Su J, Bian C, Zheng Z, et al. Pathogenic mechanisms and latest therapeutic approaches for radiation-induced lung injury: a narrative review. Crit Rev Oncol Hematol. 2024;202: 104461.","journal-title":"Crit Rev Oncol Hematol"},{"key":"14896_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1200\/JCO.2016.69.1378","volume":"35","author":"SG Chun","year":"2017","unstructured":"Chun SG, Hu C, Choy H, Komaki RU, Timmerman RD, Schild SE, et al. Impact of intensity-modulated radiation therapy technique for locally advanced non\u2013small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 randomized clinical trial. J Clin Oncol. 2017;35:56\u201362.","journal-title":"J Clin Oncol"},{"key":"14896_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ijrobp.2024.09.050","volume":"121","author":"M Weisman","year":"2025","unstructured":"Weisman M, Durm G, Shields MD, Hanna NH, Althouse S, Lautenschlaeger T. Evaluation of radiation pneumonitis in a phase 2 study of consolidation immunotherapy with nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation therapy for unresectable stage IIIA\/IIIB non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2025;121:720\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14896_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.21037\/tlcr-23-756","volume":"13","author":"D Pu","year":"2024","unstructured":"Pu D, Liu Q, Zhang S, Wang L, Xu F, Hofman P, et al. Real-world incidence and risk factors of pneumonitis in chemoradiation plus immune checkpoint inhibitors compared with chemoradiation alone in lung cancer: a retrospective cohort study. Transl Lung Cancer Res. 2024;13:139\u201351.","journal-title":"Transl Lung Cancer Res"},{"key":"14896_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.chest.2019.03.033","volume":"156","author":"AN Hanania","year":"2019","unstructured":"Hanania AN, Mainwaring W, Ghebre YT, Hanania NA, Ludwig M. Radiation-induced lung injury: assessment and management. Chest. 2019;156:150\u201362.","journal-title":"Chest"},{"key":"14896_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0272-5231(03)00126-6","volume":"25","author":"RP Abratt","year":"2004","unstructured":"Abratt RP, Morgan GW, Silvestri G, Willcox P. Pulmonary complications of radiation therapy. Clin Chest Med. 2004;25:167\u201377.","journal-title":"Clin Chest Med"},{"key":"14896_CR7","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1093\/cid\/ciad474","volume":"78","author":"DB Chastain","year":"2024","unstructured":"Chastain DB, Spradlin M, Ahmad H, Henao-Mart\u00ednez AF. Unintended consequences: risk of opportunistic infections associated with long-term glucocorticoid therapies in adults. Clin Infect Dis. 2024;78:e37-56.","journal-title":"Clin Infect Dis"},{"key":"14896_CR8","doi-asserted-by":"publisher","first-page":"17074","DOI":"10.1038\/nrdp.2017.74","volume":"3","author":"FJ Martinez","year":"2017","unstructured":"Martinez FJ, Collard HR, Pardo A, Raghu G, Richeldi L, Selman M, et al. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers. 2017;3:17074.","journal-title":"Nat Rev Dis Primers"},{"key":"14896_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejphar.2018.01.027","volume":"822","author":"YW Sun","year":"2018","unstructured":"Sun YW, Zhang YY, Ke XJ, Wu XJ, Chen ZF, Chi P. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-\u03b21\/Smad\/CTGF signaling pathway. Eur J Pharmacol. 2018;822:199\u2013206.","journal-title":"Eur J Pharmacol"},{"key":"14896_CR10","doi-asserted-by":"publisher","first-page":"8662","DOI":"10.1111\/jcmm.16821","volume":"25","author":"H Ying","year":"2021","unstructured":"Ying H, Fang M, Hang QQ, Chen Y, Qian X, Chen M. Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-\u03b21\/Smad3 pathway. J Cell Mol Med. 2021;25:8662\u201375.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"14896_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2024.07.006","volume":"120","author":"M Chen","year":"2024","unstructured":"Chen M, Hou Z, Yao Q, Chen H, Shao Q, Li M, et al. Pirfenidone in the treatment of radiation-induced lung injury: a randomized, controlled, multicenter clinical trial. Int J Radiat Oncol Biol Phys. 2024;120(2): 14.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14896_CR12","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","volume":"377","author":"PW Noble","year":"2011","unstructured":"Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. 2011;377:1760\u20139.","journal-title":"Lancet"},{"key":"14896_CR13","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King","year":"2014","unstructured":"King TE, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A phase 3 trial of Pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083\u201392.","journal-title":"N Engl J Med"},{"key":"14896_CR14","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.ijrobp.2023.02.030","volume":"116","author":"A Rimner","year":"2023","unstructured":"Rimner A, Moore ZR, Lobaugh S, Geyer A, Gelblum DY, Abdulnour RE, et al. Randomized phase 2 placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 2023;116:1091\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14896_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.radonc.2006.06.007","volume":"80","author":"I Sekine","year":"2006","unstructured":"Sekine I, Sumi M, Ito Y, Nokihara H, Yamamoto N, Kunitoh H, et al. Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patients. Radiother Oncol. 2006;80:93\u20137.","journal-title":"Radiother Oncol"},{"key":"14896_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s43556-022-00109-9","volume":"3","author":"Y Tie","year":"2022","unstructured":"Tie Y, Tang F, Peng D, Zhang Y, Shi H. TGF-beta signal transduction: biology, function and therapy for diseases. Mol Biomed. 2022;3:45.","journal-title":"Mol Biomed"},{"key":"14896_CR17","doi-asserted-by":"publisher","first-page":"121048","DOI":"10.1016\/j.lfs.2022.121048","volume":"309","author":"SA Antar","year":"2022","unstructured":"Antar SA, Saleh MA, Al-Karmalawy AA. Investigating the possible mechanisms of Pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and\/or anti-SARS-CoV-2. Life Sci. 2022;309:121048.","journal-title":"Life Sci"},{"key":"14896_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2024.117038","volume":"490","author":"WH Abdulaal","year":"2024","unstructured":"Abdulaal WH, Omar UM, Zeyadi M, El-Agamy DS, Alhakamy NA, Ibrahim SR, et al. Pirfenidone ameliorates ANIT-induced cholestatic liver injury via modulation of FXR, NF-\u043aB\/TNF-\u03b1, and Wnt\/GSK-3\u03b2\/\u03b2-catenin signaling pathways. Toxicol Appl Pharmacol. 2024;490: 117038.","journal-title":"Toxicol Appl Pharmacol"},{"key":"14896_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18059","volume":"28","author":"S Zhang","year":"2024","unstructured":"Zhang S, Wang Y, Luo D, Cheng Z, Zeng Q, Wang G, et al. Pirfenidone inhibits TGF-\u03b21-induced metabolic reprogramming during epithelial-mesenchymal transition in non-small cell lung cancer. J Cell Mol Med. 2024;28: e18059.","journal-title":"J Cell Mol Med"},{"key":"14896_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.freeradbiomed.2018.10.423","volume":"129","author":"C Bian","year":"2018","unstructured":"Bian C, Qin WJ, Zhang CY, Zou GL, Zhu YZ, Chen J, et al. Thalidomide (THD) alleviates radiation induced lung fibrosis (RILF) via down-regulation of TGF-\u03b2\/Smad3 signaling pathway in an Nrf2-dependent manner. Free Radic Biol Med. 2018;129:446\u201353.","journal-title":"Free Radic Biol Med"},{"key":"14896_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mam.2018.08.004","volume":"65","author":"D Chanda","year":"2019","unstructured":"Chanda D, Otoupalova E, Smith SR, Volckaert T, De Langhe SP, Thannickal VJ. Developmental pathways in the pathogenesis of lung fibrosis. Mol Aspects Med. 2019;65:56\u201369.","journal-title":"Mol Aspects Med"},{"key":"14896_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073766","volume":"25","author":"ME Farh","year":"2024","unstructured":"Farh ME, Kim HJ, Kim SY, Lee JH, Lee H, Cui R, et al. Transcriptional changes in radiation-induced lung injury: a comparative analysis of two radiation doses for preclinical research. Int J Mol Sci. 2024;25: 3766.","journal-title":"Int J Mol Sci"},{"key":"14896_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11081457","volume":"11","author":"M Yang","year":"2022","unstructured":"Yang M, Fan Q, Hei TK, Chen G, Cao W, Meng G, et al. Single-cell transcriptome analysis of radiation pneumonitis mice. Antioxidants. 2022;11: 1457.","journal-title":"Antioxidants"},{"key":"14896_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13014-016-0580-3","volume":"11","author":"C Henkenberens","year":"2016","unstructured":"Henkenberens C, Janssen S, Lavae-Mokhtari M, et al. Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience. Radiat Oncol. 2016;11:12.","journal-title":"Radiat Oncol"},{"issue":"7","key":"14896_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1335","volume":"12","author":"A Torre","year":"2024","unstructured":"Torre A, Mart\u00ednez-S\u00e1nchez FD, Narvaez-Ch\u00e1vez SM, Herrera-Islas MA, Aguilar-Salinas CA, C\u00f3rdova-Gallardo J. Pirfenidone use in fibrotic diseases: what do we know so far? Immun Inflamm Dis. 2024;12(7): e1335.","journal-title":"Immun Inflamm Dis"},{"issue":"1","key":"14896_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s10753-017-0671-9","volume":"41","author":"R Rasooli","year":"2018","unstructured":"Rasooli R, Pourgholamhosein F, Kamali Y, Nabipour F, Mandegary A. Combination therapy with pirfenidone plus prednisolone ameliorates paraquat-induced pulmonary fibrosis. Inflammation. 2018;41(1):134\u201342.","journal-title":"Inflammation"},{"key":"14896_CR27","doi-asserted-by":"publisher","first-page":"107822","DOI":"10.1016\/j.lungcan.2024.107822","volume":"192","author":"IS Voruganti Maddali","year":"2024","unstructured":"Voruganti Maddali IS, Cunningham C, McLeod L, Bahig H, Chaudhuri N, Chua LM. Optimal management of radiation pneumonitis: findings of an international Delphi consensus study. Lung Cancer. 2024;192:107822.","journal-title":"Lung Cancer"},{"key":"14896_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12890-020-01376-4","volume":"21","author":"M Arroyo-Hern\u00e1ndez","year":"2021","unstructured":"Arroyo-Hern\u00e1ndez M, Maldonado F, Lozano-Ruiz F, Mu\u00f1oz-Monta\u00f1o W, Nu\u00f1ez-Baez M, Arrieta O. Radiation-induced lung injury: current evidence. BMC Pulm Med. 2021;21:9.","journal-title":"BMC Pulm Med"},{"key":"14896_CR29","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ijrobp.2023.10.044","volume":"118","author":"ME Kuipers","year":"2024","unstructured":"Kuipers ME, van Doorn-Wink KC, Hiemstra PS, Slats AM. Predicting radiation-induced lung injury in patients with lung cancer: challenges and opportunities. Int J Radiat Oncol Biol Phys. 2024;118:639\u201349.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14896_CR30","doi-asserted-by":"publisher","first-page":"170057","DOI":"10.1183\/16000617.0057-2017","volume":"26","author":"LH Lancaster","year":"2017","unstructured":"Lancaster LH, de Andrade JA, Zibrak JD, Padilla ML, Albera C, Nathan SD, et al. Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis. Eur Respir Rev. 2017;26:170057.","journal-title":"Eur Respir Rev"},{"key":"14896_CR31","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00084-2018","volume":"4","author":"V Cottin","year":"2018","unstructured":"Cottin V, Koschel D, G\u00fcnther A, Albera C, Azuma A, Sk\u00f6ld CM, et al. Long-term safety of pirfenidone: results of the prospective, observational passport study. ERJ Open Res. 2018;4: 00084\u20132018.","journal-title":"ERJ Open Res"},{"key":"14896_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pdpdt.2018.11.015","volume":"25","author":"B Ferrer Guill\u00e9n","year":"2019","unstructured":"Ferrer Guill\u00e9n B, Gi\u00e1caman MM, Valenzuela O\u00f1ate C, Magdaleno Tapial J, Hern\u00e1ndez Bel P, P\u00e9rez ferriols A. Pirfenidone-induced photosensitivity confirmed by pathological phototest. Photodiagnosis Photodyn Ther. 2019;25:103\u20135.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"14896_CR33","doi-asserted-by":"publisher","first-page":"614","DOI":"10.5021\/ad.2018.30.5.614","volume":"30","author":"HJ Kim","year":"2018","unstructured":"Kim HJ, Seo JW, Kim TH, Choi SH, Song KH, Kim KH. Pirfenidone-induced photosensitivity in a patient with idiopathic pulmonary fibrosis. Ann Dermatol. 2018;30:614\u20136.","journal-title":"Ann Dermatol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14896-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14896-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14896-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:13:42Z","timestamp":1757477622000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14896-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14896"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14896-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki, and approval was obtained from the Ethics Committee of the Second Affiliated Hospital of Guizhou Medical University. The requirement for written informed consent was waived by the Ethics Committee of the Second Affiliated Hospital of Guizhou Medical University due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1415"}}